ADVISORY, May 4, 2012 (GLOBE NEWSWIRE) --
MELA Sciences, Inc. [MELA], the medical device company that has developed MelaFind®,will visit the NASDAQ MarketSite in Times Square in recognition of Melanoma Monday® and to kick-off Melanoma/Skin Cancer Detection and Prevention Month®, as well as raise awareness about early detection of melanoma. Every hour, one American dies of melanoma and approximately fifteen are diagnosed with the disease.
In honor of the occasion, leading New York dermatologist Dr. Doris Day will ring the Opening Bell with Dr. Joseph Gulfo, President and CEO of MELA Sciences.
MELA Sciences will be supporting the American Academy of Dermatology's Melanoma Monday early detection efforts by sponsoring free skin cancer screenings, which will be administered by board certified dermatologists onsite for NASDAQ staff, analysts and members of the media. The MelaFind device, a brand new medical technology that may be used by dermatologists to obtain additional information for a biopsy decision to detect melanoma, will be available to aid in the skin examinations.
Melanoma/Skin Cancer Detection and Prevention Month® and Melanoma Monday® are registered trademarks of the American Academy of Dermatology. The American Academy of Dermatology does not endorse or recommend any commercial products or services.
NASDAQ MarketSite – 4 Times Square – 43rd & Broadway – Broadcast Studio
Monday, May 7, 2012 – 9:15 a.m. to 9:30 a.m. ET
Analyst Meeting – 10 a.m. to 11 a.m. ET
Free Skin Cancer Screenings – 10 a.m. to Noon ET
Fiber Line (Encompass Waterfront): 4463
Gal 3C/06C 95.05 degrees West
18 mhz Lower
DL 3811 Vertical
Facebook and Twitter:
For multimedia features such as exclusive content, photo postings, status updates and video of bell ceremonies please visit our Facebook page at:
For news tweets, please visit our Twitter page at:
A live webcast of the NASDAQ Opening Bell will be available at:
To obtain a hi-resolution photograph of the Market Open, please go to http://www.nasdaq.com/reference/marketsite_events.stm and click on the market open of your choice.
About MELA Sciences:
MELA Sciences is a medical device company focused on the commercialization of its flagship product, MelaFind®, and its further design and development. MelaFind is a non-invasive tool to provide additional information to dermatologists during melanoma skin examinations. The device uses light from visible to near-infrared wavelengths to evaluate skin lesions up to 2.5 mm beneath the skin. The device provides information on a lesion's level of morphologic disorganization to provide additional objective information that may be used by dermatologists in the biopsy decision-making process. MelaFind has been approved by the US Food and Drug Administration for use in the US. In addition, MelaFind has received CE Mark approval and is approved for use in the European Union.
For more information on MELA Sciences, visit www.melasciences.com.
About NASDAQ OMX:
The inventor of the electronic exchange, The NASDAQ OMX Group, Inc., fuels economies and provides transformative technologies for the entire lifecycle of a trade - from risk management to trade to surveillance to clearing. In the US and Europe, we own and operate 24 markets, 3 clearinghouses and 5 central securities depositories supporting equities, options, fixed income, derivatives, commodities, futures and structured products. Able to process more than 1 million messages per second at sub-40 microsecond speeds with 99.999% uptime, our technology drives more than 70 marketplaces in 50 developed and emerging countries into the future, powering 1 in 10 of the world's securities transactions. Our award-winning data products and worldwide indexes are the benchmarks in the financial industry. Home to approximately 3,400 listed companies worth $5.1 trillion in market cap whose innovations shape our world, we give the ideas of tomorrow access to capital today. Welcome to where the world takes a big leap forward, daily. Welcome to the NASDAQ OMX Century. To learn more, visit www.nasdaqomx.com. Follow us on Facebook (http://www.facebook.com/NASDAQ) and Twitter (http://www.twitter.com/nasdaqomx). (Symbol: NDAQ and member of S&P 500)
In This StoryNDAQ
Nasdaq Press Center
Read the latest press releases, request a press kit, and get in touch with our press team.